|
Penin-Franch A, Garcia-Vidal JA, Martinez CM, Escolar-Reina P, Martinez-Ojeda RM, Gomez AI, Bueno JM, Minaya-Munoz F, Valera-Garrido F, Medina-Mirapeix F, Pelegrin P. Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon. Elife. 2022 Feb 24;11:e73675. doi: 10.7554/eLife.73675. PubMed PMID: 35199642; PubMed Central PMCID: PMC8896827.
AÑO: 2022; IF: 7.7
|
35199642
|
Weber ANR, Tapia-Abellan A, Liu X, Arostegui JI, Pelegrin P, Welzel T, Kuemmerle-Deschner JB. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply. Rheumatology (Oxford). 2023 May 2;62(5):e168-e169. doi: 10.1093/rheumatology/keac718. No abstract available. PubMed PMID: 36562561.
AÑO: 2023; IF: 4.7
|
|
Weber ANR, Tapia-Abellan A, Liu X, Dickhofer S, Arostegui JI, Pelegrin P, Welzel T, Kuemmerle-Deschner JB. Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3. Rheumatology (Oxford). 2022 Oct 6;61(10):e299-e313. doi: 10.1093/rheumatology/keac273. No abstract available. PubMed PMID: 35579347.
AÑO: 2022; IF: 5.5
|
|
Hurtado-Navarro L, Baroja-Mazo A, Pelegrin P. Characterization of P2X7 Receptors in Human Blood Cells. Methods Mol Biol. 2022;2510:279-290. doi: 10.1007/978-1-0716-2384-8_15. PubMed PMID: 35776331.
AÑO: 2022
|
|
Villalba-Lopez F, Garcia-Bernal D, Mateo SV, Vidal-Correoso D, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, Lopez-Lopez V, Rios-Zambudio A, Cascales P, Pons JA, Ramirez P, Pelegrin P, Baroja-Mazo A. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation. Biomed Pharmacother. 2023 Nov;167:115529. doi: 10.1016/j.biopha.2023.115529. Epub 2023 Sep 18. PubMed PMID: 37729732.
AÑO: 2023; IF: 6.9
|